MedPath

ADTRALZA 150 mg SOLUCION INYECTABLE EN JERINGA PRECARGADA

ADTRALZA 150 mg SOLUCION INYECTABLE EN JERINGA PRECARGADA

Commercialized
Register Number

1211554002

Prescription Type

Diagnóstico Hospitalario

Authorization Date

Jul 27, 2021

Dosage Form

SOLUCIÓN INYECTABLE

Route: VÍA SUBCUTÁNEA

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number1211554002
EMA Approved
Yes

Drug Classification

Generic
No
Orphan
No
Biosimilar
No
Commercialized
Yes
CIMA AEMPS Classification

INGREDIENTS (1)

TRALOKINUMABActive
Quantity: 150 mg
Name: TRALOKINUMAB

ATC CLASSIFICATION (3)

D11A
D11AH
D11AH07

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.